期刊文献+

用药教育对肾病综合征患者使用华法林抗凝治疗效果的影响 被引量:5

Effects of Medication Education on Warfarin Anticoagulation Therapy for Patients with Nephrotic Syndrome
原文传递
导出
摘要 目的:探讨用药教育对肾病综合征(NS)患者使用华法林抗凝治疗效果的影响。方法:将153例NS患者分为治疗组(108例)和对照组(45例),两组患者均预防性使用华法林抗凝治疗,其中临床药师对治疗组患者进行用药教育。比较两组患者的抗凝疗效、国际标准化比值(INR)的监测频率、用药依从性和出血事件发生率。结果:治疗组和对照组患者抗凝达标率分别为19.4%和6.7%,出院后平均INR监测频率分别为(20.7±8.4)d和(32.5±3.5)d,对照组患者用药不依从情况较治疗组显著增多,两组比较差异均有统计学意义(P<0.05)。两组患者轻微出血事件的发生率相当,差异无统计学意义(P>0.05)。结论:对使用华法林抗凝治疗的NS患者进行用药教育可提高抗凝效果和患者的用药依从性。 OBJECTIVE: To explore the effects of medication education on warfarin anticoagulation therapy for patients with nephrotic syndrome (NS). METHODS: 153 NS patients were dvided into treatment group (108 cases) and control group (45 cas- es). Both groups were given warfarin anticoagulation therapy, and in treatment group clinical pharmacists provided medication edu- cation for patients. The anticoagulant effect, the average monitoring frequency of INR, drug compliance and the incidence of bleed- ing were compared between 2 groups. RESULTS: The success rates of anticoagulation were 19.4% and 6.7 % in treatment group and control group; the average monitoring frequency of INR were(20.7 + 8.4)d and(32.5 _+ 3.5) d. Compared with treatment group, the medication incompliance of control group were increased significantly, and there was significant difference between 2 groups (P〈0.05). The incidence of mild bleeding in 2 groups were similar to each group, there was no statistical significance (P〉0.05). CONCLUSIONS: The medical education of warfarin can improve the anticoagulant effect and the patients compliance.
出处 《中国药房》 CAS CSCD 2013年第28期2626-2628,共3页 China Pharmacy
关键词 华法林 用药教育 肾病综合征 抗凝治疗 Warfarin Medication education Nephrotic syndrome Anticoagulation therapy
  • 相关文献

参考文献7

二级参考文献20

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2Paul DS. Antithrombotic therapy in patients with mechanical and biological heart valves[ J]. Chest, 1992,102 (4 Suppl) :4453.
  • 3Stein PD,Alpert JS,Bussey HI,et al. Antithrombotic therapy in patients with mechanical and biological heart valves [J]. Chest,2001,119(1 Suppl) :220-227.
  • 4Pruefer D, Dahm M, Dohmen G, et al. Intensity of oral anticoagulation after implantation of St-Jude medical mitral or multitude valve replacement:lessons leared from GELIA(GELIA5) [J]. Eur Heart J,2001, ( Suppl Q) :39-43.
  • 5Eriksson P, Nilsson L, Karpe F, et al. Very low density lipoprotein response element in the promotor region of the human plasminogen active inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia [J]. Arterioscler Thormb Vasc Biol
  • 6Gohlke-Barwolf C, Acar J, Oakley C, et al. Gudlines for prevention of thromboembolic events in valvular heart disease [J]. Eur Heart J,1995,16 (10): 1320-1330.
  • 7Hart RG,Benavente O,McBride R,et al.Antithrombotic therapy to prevent stroke in patients with atrial fibrillation:a rmeta-analysis.Ann Intern Med,1999,131:492-501.
  • 8Hirsh J,Fuster V,Ansell J,et al.American Heart Association/American College of Cardiology Foundation guide to warfarin therapy.J Am Coll Cardiol,2003,41:1633-1652.
  • 9Hylek EM,Skates S J,Sheehan MA,et al.An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.N Engl J Med,1996,335:540-546.
  • 10Gullov AL,Koefoed BG,Petersen P,et al.Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation:Second Copenhagen Atrial Fibrillation,Aspirin,and Anticoagulation Study.Arch Intern Med,1998,158:1513-1521.

共引文献192

同被引文献62

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部